Inflammatix Completes Technical Development for TriVerity(TM) Acute Infection and Sepsis Test System

Source :: PR Newswire. November 15, 2023
Publication Year :: 2023
Abstract: Company Reaches Important Product Development Milestone with its Myrna(TM) Instrument and TriVerity Cartridge SUNNYVALE, Calif., Nov. 15, 2023 /PRNewswire/ -- Inflammatix, Inc., a pioneering molecular diagnostics company, announced today that [...]

Subjects :: United States. Food and Drug Administration
Medical research -- Health aspects
Medicine, Experimental -- Health aspects
Medical tests -- Health aspects
Product development -- Health aspects
Bacterial infections -- Health aspects
Infection -- Health aspects
Virus diseases -- Health aspects
Time to market
Business
News, opinion and commentary

Tools